Back to Top

"One of today's leaders in investor relations and shareholder services"

Category Archives: Articles

Cannabidiol as a Treatment for Restless Leg Syndrome

AXIM Has Made Major Moves Already in 2017

Cannabidiol as a Treatment for Restless Leg Syndrome

2017 has been an active year for AXIM Biotech (OTCQX: AXIM), with a new services agreement and patent filing updates. AXIM entered into a new services agreement with a contract research organization in Israel, focusing on a clinical proof-of-concept study of its Gabapentin and cannabidiol chewing gum product line. The study will test the effectiveness of this product in the treatment of restless leg syndrome.

About Restless Leg Syndrome

Restless leg syndrome, sometimes known as Willis-Ekbom Disease, is a persistent condition that causes irritating sensations in the legs. Sufferers of this syndrome have the unpleasant urge to move their legs, often during the night when they are trying to sleep. The condition often worsens during long periods of inactivity, having a significant effect on the sufferer’s ability to get adequate rest. It is believed that the cause of restless leg syndrome is in the brain, and it can lead …

Continue Reading

Posted in Articles| Tagged , , |
Medical Marijuana, Inc. (MJNA)

2017 Becoming a Banner Year for MJNA Revenue Growth

Medical Marijuana, Inc. (MJNA)

The legalization of marijuana has created new opportunities for businesses. Openings for those growing marijuana and selling high-grade medical marijuana products have arisen. Medical Marijuana, Inc. (MJNA) fulfilled the need for a company that sells medicinal marijuana products like hemp oil. As the company has grown over the past eight years, so has the company’s revenue. And this year (2017) has become a banner year for the company in terms of revenue growth.

Who MJNA is

MJNA is the first publicly traded U.S. cannabis company. They strive to provide consumers with innovative ideas in the hemp industry. In addition to the products offered, MJNA wants to create awareness about the industry. They pride themselves on their eco-friendly products. President and CEO, Dr. Stuart Titus, Ph. D, was once a board member but now heads the company. Dr. Titus and his team are taking the industry by storm through their …

Continue Reading

Posted in Articles| Tagged , , , |

Pazoo, Inc. is Growing Up Fast in 2017

In one of the latest segments of SmallCapVoice.com’s Online Business Briefing, host Stuart T. Smith interviewed the CEO and co-founder, David Cunic, about his innovative company, Pazoo, Inc, that specializes in testing marijuana for safety and consistency. The opinion of David is that when parents give their children antibiotics or any other type of medicine, they want to be sure that the medicine is safe and the proper dosage. The only way to do that is through continuous testing of the product. The same goes for marijuana, whether it is used for medical or recreational use.

To look at it another way, consider moonshine, David asks of the listener. If you had the choice of buying moonshine from the liquor store where it has passed regulations and testing before hitting the shelves or from a batch made in some stranger’s back yard, you’re going to choose the former. Again, …

Continue Reading

Posted in Articles| Tagged , , |
Kannaway LLC (MJNA)

A Closer Look at Kannaway LLC

Kannaway LLC (MJNA)

We’re always in search of other leaders in the cannabis industry who support and provide products to those who utilize the healing powers of medicinal marijuana and other similar products. Kannaway LLC is a subsidiary of Medical Marijuana, Inc. (OTC: MJNA). Kannaway reigns as the first lifestyle network to provide hemp-based botanical products to consumers. Their innovated products supply consumers with access to herbal blends and oils that support health and wellness through natural means.

Who Kannaway Is

Kannaway continuously strives to provide individuals with holistically sound choices for supplements and skincare products. They’re the first direct marketing company of its kind to give consumers access to legal hemp products. In 2014, the Academy of Multi-level Marketing awarded them with the title of “Start-up of the Year,” which was attributed to their rapid growth and solid foundation. Today, they’re continuing to guide the path of the cannabis market in …

Continue Reading

Posted in Articles| Tagged , , , , |
AXIM

Medical Cannabis-Based Gum Moves into Production for Clinical Trials

AXIM

As of May 2, 2017, one of the world leaders in cannabinoid research and development declared their product development partner, Quay Pharmaceuticals Ltd., also known as Quay Pharma, acquired a license from the British Home Office to continue research related to AXIM’s MedChew Rx® line of pharmaceutical chewing gum. This particular license allows the British-based pharmaceutical company to work with controlled drugs in order to continue with the development process of the product.

Currently, MedChew RX® is made with 5 mg of cannabidiol (CBD) as well as an equivalent dosage of tetrahydrocannabinol (THC). When the drug does hit the market, it’ll be used to treat pain and spasms in patients who have multiple sclerosis (MS). This particular condition is a degenerative disease that affects the central nervous system and disrupts how the brain and body communicate with one another. Current research published by the National Organization for the Reform …

Continue Reading

Posted in Articles| Tagged , , , |
Medical Marijuana (MJNA)

MJNA Financial Numbers Tell Story of a Company on the Rise

Medical Marijuana (MJNA)

Medical Marijuana, Inc., traded publicly under the ticker symbol MJNA, has made history as the world’s first cannabis company to be publicly traded in the United States. 2016 was a big year for the company with record growth, international import permissions being granted by multiple government agencies, and promising clinical trial results from MJNA’s revolutionary product lines.

Financial Growth

In the last quarter of 2016, Medical Marijuana, Inc.’s revenue increased by 66 percent compared to the first quarter of 2016. The company also had a Net Comprehensive Income increase of 731 percent compared to the same figure in 2015. Finishing out 2016 with a net income of greater than $8 million, the company is poised to break even more financial records in 2017. At least part of MJNA’s landmark success can be attributed to its portfolio of subsidiaries and investments, including new IP filings, international licensing and promising findings …

Continue Reading

Posted in Articles| Tagged , , , , |